Our aim is to deliver life-changing products and connected health solutions to patients worldwide with sleep apnoea or other respiratory conditions, and to spread awareness about these conditions and treatments. Our objective is two-fold:
We sell a comprehensive range of products in more than 140 countries worldwide through direct offices and a network of distributors. Plus approximately 18.5 million ResMed devices are cloud-connected, sharing actionable data with clinicians and patients themselves to improve their therapy experience, adherence, and overall health.
Dedicating 7-8% of annual revenue to research and development, we are committed to advancing innovative technology in sleep and respiratory medicine, to commercialising innovative products that incorporate these technologies around the world, and exercising the highest standards of ethics and quality at all times.